Related Experiment Video
Updated: Jun 8, 2026

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
Published on: June 26, 2020
Human parechovirus 3 causing sepsis-like illness in children from midwestern United States
Rangaraj Selvarangan1, Masha Nzabi, Suresh B Selvaraju
1Department of Pathology and Laboratory Medicine, Children's Mercy Hospital, Kansas City, MO, USA. rselvarangan@cmh.edu
Insights
Human parechovirus (HPeV) central nervous system (CNS) infections are prevalent in US infants, often presenting as sepsis-like illness during summer and fall. Early HPeV and enterovirus testing in infants can improve diagnosis and management.
Area of Science:
- Pediatric Infectious Diseases
- Virology
- Epidemiology
Background:
- Human parechovirus (HPeV) CNS infections in children can lead to severe outcomes like neonatal sepsis, meningitis, or paralysis.
- Prevalence and clinical presentation of HPeV CNS infections in US children remain under-investigated.
Purpose of the Study:
- To determine the prevalence of HPeV CNS infections in children in the United States.
- To describe the clinical presentation of HPeV CNS infections in pediatric patients.
Main Methods:
- Cerebrospinal fluid (CSF) samples from enterovirus-negative pediatric patients (2006-2008) were tested for HPeV using real-time RT-PCR.
- HPeV genotyping was performed by sequencing the VP3/VP1 junction.
- Demographic and clinical data were retrospectively collected from medical records.
Main Results:
- HPeV was detected in 7% of tested CSF samples, with a notable increase in 2007 (17%).
- HPeV-3 was the predominant genotype, with infections occurring seasonally (June-October) in male infants (71%) presenting with sepsis-like illness (66%).
- Common symptoms included irritability (98%) and fever (95%); neurological manifestations were infrequent (5%).
Conclusions:
- This study reports the first multiyear prevalence of HPeV CNS infections in the US, primarily affecting male infants with sepsis-like illness during warmer months.
- HPeV CNS infections were comparable in prevalence to enterovirus infections in 2007.
- Routine seasonal CSF testing for both HPeV and enterovirus in infants may enhance diagnostic accuracy and clinical management of sepsis-like presentations.
Background:
: Human parechovirus (HPeV) infections of the central nervous system (CNS) in children can be associated with severe outcomes such as neonatal sepsis-like illness, meningitis, or paralysis. We sought to determine the prevalence of HPeV CNS infections and clinical presentation in children from the United States.
Methods:
: Frozen nucleic acid extracts from enterovirus-negative cerebrospinal fluid (CSF) obtained at the Children's Mercy Hospitals and Clinics, in Kansas City from 2006 (n = 242), 2007 (n = 324), and 2008 (n = 218) were tested by 2-step HPeV real-time reverse transcription polymerase chain reaction. HPeV genotype was determined by sequencing the VP3/VP1 junction. Demographic and clinical data were abstracted from medical records.
Results:
: Overall HPeV was detected in 58/780 (7%) of tested CSF samples; 4/218 (2%) in 2006, 54/320 (17%) in 2007, and 0/242 (0%) in 2008. HPeV (17%) and enterovirus (20%) detection were comparable in 2007. HPeV-3 genotype was detected in 52/53 specimens successfully sequenced. Detection was seasonal (June-October). HPeV-3-CNS-infection occurred at a mean age of 6.6 ± 4.4 weeks and predominantly in males (71%). The most common clinical presentation was sepsis-like syndrome (66%). The most common symptoms were irritability (98%), fever (95%), and nonspecific rash (58.6%), while neurologic manifestations were rare (5%).
Conclusions:
: To our knowledge, this is the first multiyear prevalence report of HPeV CNS infection in the United States. HPeV CNS infection was detected mostly in male infants with sepsis-like illness during the late summer/autumn season. Routine seasonal CSF testing in infants for HPeV plus enterovirus may improve etiologic detection and clinical management of infantile sepsis-like presentations.
Related Concept Videos
Poliomyelitis
Respiratory Syncytial Virus Disease
Viral Meningitis
Chickenpox
Cytomegalovirus Disease
Encephalitis l: Introduction